Telix Pharmaceuticals | TLX - Ordinary Share Capital

Stock Price
10.22
Daily Change
1.02 11.03%
Monthly
-13.87%
Yearly
-66.38%
Q1 Forecast
10.21

Telix Pharmaceuticals reported AUD338.78M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Cochlear AUD 1.18B 19.2M Dec/2024
CSL USD 576M 19M Dec/2024
Integral Diagnostics AUD 335.09M 1.07M Jun/2024
Mayne Pharma AUD 81.25M 0 Jun/2025
Medical Developments International AUD 115.01M 9.28M Dec/2024
Mesoblast USD 1.28B 127.49M Jun/2025
Neuren Pharmaceuticals AUD 165.27M 10.43M Dec/2024
Pacific Edge NZD 1.02B 210.22M Dec/2025
Paradigm Biopharmaceuticals AUD 253.24M 15.12M Dec/2024
Polynovo AUD 191.6M 0 Jun/2024
PYC Therapeutics AUD 230.58M 0 Dec/2024
Ramsay Health Care AUD 2.27B 19.6M Dec/2024
ResMed USD 145.66M 144.9M Dec/2025
Sonic Healthcare AUD 4.15B 467K Dec/2024